U.S. Health Secretary Robert F. Kennedy Jr.'s recent dismissal of all 17 members of the CDC's Advisory Committee on Immunization Practices (ACIP) has triggered a strong backlash from vaccine experts. The ousted panelists warn that the abrupt shakeup may undermine public health, reduce access to lifesaving vaccines, and increase the risk of preventable disease outbreaks.
Kennedy, a longtime vaccine skeptic, replaced the committee with eight new appointees, some of whom have publicly questioned vaccine safety. The decision was made just two days after the firings on June 9, 2025. In a joint article published in the Journal of the American Medical Association (JAMA), the former ACIP members expressed alarm over what they described as a destabilizing and unjustified overhaul.
They argue that the move, along with cuts to CDC immunization staff, weakens the national vaccine program and threatens decades of progress. “These decisions, made without clear rationale, may roll back the achievements of U.S. immunization policy,” the experts wrote. They emphasized the potential risk to public trust and the safety of families across the country.
Kennedy claimed the firings were necessary to eliminate alleged conflicts of interest among the previous panel members, many of whom were appointed during the Biden administration. However, he provided no evidence of specific misconduct or bias.
Health professionals and scientists warn that politicizing vaccine oversight could erode confidence in health authorities and negatively impact vaccine uptake. The Department of Health and Human Services has not yet responded to media inquiries regarding the controversy.
Kennedy’s sweeping changes mark a significant shift in U.S. health policy and come amid growing concerns over misinformation and vaccine hesitancy.


Mike Rogers Calls for End to US-Canada Tariff War
Novartis Shares Plunge After Muscle Drug Fails Phase III Trial
Trump Backs Florida Golf Course as Presidential Retreat
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars
Trump Weighs FBI Probe Into Nolan Wells’ Death
EU Gives Crypto Platforms Three Months to Remove USDT Under MiCA Rules
Venezuela Earthquake Health Risks Rise as Disease Monitoring Intensifies
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback
US Pressures Allies to Distance From Anti-Disinformation Conference
Marco Rubio Warns Russia-Ukraine War Could Spark Wider Conflict
Illinois Delays Crypto Tax Law Until July 2027
Merz Warns of Extremism After AfD Gains Power in Saxony-Anhalt
FDA Approves Mirum’s Atebrioz for Rare Bone Disorder FOP
Trump Says He Deserves 2026 Nobel Peace Prize Despite Uncertain Chances
EU Rejects Italy, Greece Calls for Fiscal Rule Flexibility
3 clinical-grade skincare creams you really shouldn’t buy online
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+ 



